Cita APA

Glantz, S. A. (2018). PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes. Tob Control.

Chicago Style Citation

Glantz, Stanton A. "PMI’s Own in Vivo Clinical Data On Biomarkers of Potential Harm in Americans Show That IQOS Is Not Detectably Different From Conventional Cigarettes." Tob Control 2018.

Cita MLA

Glantz, Stanton A. "PMI’s Own in Vivo Clinical Data On Biomarkers of Potential Harm in Americans Show That IQOS Is Not Detectably Different From Conventional Cigarettes." Tob Control 2018.